OTC Scar Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global Over-the-Counter (OTC) Scar Treatment market achieved significant growth, with worldwide revenue totaling US$ 9 billion in 2024. A report by Fairfield Market Research predicts a steady ascent, By the end of 2031, the market is anticipated to reach a valuation of US$ 12.3 billion.

Factors Fueling OTC Scar Treatment Products:

Emergence of New Treatment Formulations: OTC scar treatment products are gaining traction due to the development of innovative formulations. Emollients with potent bioactive compounds, such as cannabinoid receptor modulators, natural moisturizing agents, lipids, ceramides, and antioxidants, are being researched for their efficacy in treating conditions like atopic dermatitis. These formulations provide improved treatment compliance, tolerability, and reduced corticosteroid use, presenting growth opportunities for manufacturers.

Challenges to Market Expansion:

Lack of Clinical Data on Product Efficacy: The absence of comprehensive clinical data supporting the efficacy of OTC scar treatment products, compounded by research limitations and insufficient sample sizes, hampers market growth.

Country-wise Insights:

U.S. OTC Scar Treatment Market Overview

The U.S. OTC scar treatment market is on the rise due to increasing acne cases, making topical scar treatment products more accessible. The United States dominated the North America OTC scar treatment market share. This growth is fueled by easy product availability and higher disposable income levels.

Germany's Attractive OTC Scar Treatment Market

Germany had a significant share of the Europe OTC scar treatment market , making it an appealing market for providers. Established manufacturers in Germany and ongoing research on natural compounds in scar treatment gels contribute to steady market growth with a projected annual increase.

China's Impact on the Global OTC Scar Treatment Market

China played a crucial role in the East Asia OTC scar treatment market and globally. Traditional Chinese medicines' effectiveness in treating skin issues drives market growth, particularly due to a higher tendency for skin hyperpigmentation after injuries in Asian skin types. China remains a key player in the global OTC scar treatment market with a wide range of effective products.

Competitive Landscape:

Key manufacturers of OTC scar treatment products are focusing on expanding their global market presence through extensive marketing and product penetration strategies. The market is characterized by fragmentation, with key players launching new products to enhance their portfolios.

Key Companies Profiled:

Smith & Nephew PLC
Merz Inc.
Enaltus LLC
Occulus Innovative Sciences Inc.
CCA Industries Inc.
Cynosure Inc.
Avita Medical Limited
Lumenis
Syneron Medical Ltd.
Nutramarks Inc.
Molnlycke Health Care
Pacific World Corporation
Valeant Pharmaceuticals International Inc.
Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers)
SkinCeuticals
A. Menarini Singapore Pte. Ltd.

OTC Scar Treatment Industry Research Segmentation

By Product:

Topical Scar Products

Gels

Creams/Ointments

Oils

Sheets

Others

By Application:

Atrophic Scars
Hypertrophic Scars and Keloids
Contractures
Burns
Stretch Marks

By Distribution Channel:

Hospitals Pharmacies
Retail Pharmacies
E-Commerce

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global OTC Scar Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global OTC Scar Treatment Market Outlook, 2018 - 2031

3.1. Global OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Topical Scar Products
    - 3.1.1.1.1. Gels
    - 3.1.1.1.2. Creams/Ointments
    - 3.1.1.1.3. Oils
    - 3.1.1.1.4. Sheets
  - 3.1.1.2. Others
3.2. Global OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Atrophic Scars
  - 3.2.1.2. Hypertrophic Scars and Keloids
  - 3.2.1.3. Contractures
  - 3.2.1.4. Burns
  - 3.2.1.5. Stretch Marks
3.3. Global OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Hospitals Pharmacies
  - 3.3.1.2. Retail Pharmacies
  - 3.3.1.3. E-Commerce
3.4. Global OTC Scar Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America OTC Scar Treatment Market Outlook, 2018 - 2031

4.1. North America OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Topical Scar Products
    - 4.1.1.1.1. Gels
    - 4.1.1.1.2. Creams/Ointments
    - 4.1.1.1.3. Oils
    - 4.1.1.1.4. Sheets
  - 4.1.1.2. Others
4.2. North America OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Atrophic Scars
  - 4.2.1.2. Hypertrophic Scars and Keloids
  - 4.2.1.3. Contractures
  - 4.2.1.4. Burns
  - 4.2.1.5. Stretch Marks
4.3. North America OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospitals Pharmacies
  - 4.3.1.2. Retail Pharmacies
  - 4.3.1.3. E-Commerce
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.4.1.2. U.S. OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.3. U.S. OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 4.4.1.4. Canada OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.4.1.5. Canada OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.6. Canada OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe OTC Scar Treatment Market Outlook, 2018 - 2031

5.1. Europe OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Topical Scar Products
    - 5.1.1.1.1. Gels
    - 5.1.1.1.2. Creams/Ointments
    - 5.1.1.1.3. Oils
    - 5.1.1.1.4. Sheets
  - 5.1.1.2. Others
5.2. Europe OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Atrophic Scars
  - 5.2.1.2. Hypertrophic Scars and Keloids
  - 5.2.1.3. Contractures
  - 5.2.1.4. Burns
  - 5.2.1.5. Stretch Marks
5.3. Europe OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospitals Pharmacies
  - 5.3.1.2. Retail Pharmacies
  - 5.3.1.3. E-Commerce
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.2. Germany OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.3. Germany OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 5.4.1.4. U.K. OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.5. U.K. OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.6. U.K. OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 5.4.1.7. France OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.8. France OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.9. France OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 5.4.1.10. Italy OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.11. Italy OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.12. Italy OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 5.4.1.13. Turkey OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.14. Turkey OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.15. Turkey OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 5.4.1.16. Russia OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.17. Russia OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.18. Russia OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 5.4.1.19. Rest of Europe OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.4.1.20. Rest of Europe OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.21. Rest of Europe OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific OTC Scar Treatment Market Outlook, 2018 - 2031

6.1. Asia Pacific OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Topical Scar Products
    - 6.1.1.1.1. Gels
    - 6.1.1.1.2. Creams/Ointments
    - 6.1.1.1.3. Oils
    - 6.1.1.1.4. Sheets
  - 6.1.1.2. Others
6.2. Asia Pacific OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Atrophic Scars
  - 6.2.1.2. Hypertrophic Scars and Keloids
  - 6.2.1.3. Contractures
  - 6.2.1.4. Burns
  - 6.2.1.5. Stretch Marks
6.3. Asia Pacific OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals Pharmacies
  - 6.3.1.2. Retail Pharmacies
  - 6.3.1.3. E-Commerce
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.2. China OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.3. China OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 6.4.1.4. Japan OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.5. Japan OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.6. Japan OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 6.4.1.7. South Korea OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.8. South Korea OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.9. South Korea OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 6.4.1.10. India OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.11. India OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.12. India OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 6.4.1.13. Southeast Asia OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.14. Southeast Asia OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.15. Southeast Asia OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America OTC Scar Treatment Market Outlook, 2018 - 2031

7.1. Latin America OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Topical Scar Products
    - 7.1.1.1.1. Gels
    - 7.1.1.1.2. Creams/Ointments
    - 7.1.1.1.3. Oils
    - 7.1.1.1.4. Sheets
  - 7.1.1.2. Others
7.2. Latin America OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Atrophic Scars
  - 7.2.1.2. Hypertrophic Scars and Keloids
  - 7.2.1.3. Contractures
  - 7.2.1.4. Burns
  - 7.2.1.5. Stretch Marks
7.3. Latin America OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals Pharmacies
  - 7.3.1.2. Retail Pharmacies
  - 7.3.1.3. E-Commerce
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.4.1.2. Brazil OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.3. Brazil OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 7.4.1.4. Mexico OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.4.1.5. Mexico OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.6. Mexico OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 7.4.1.7. Argentina OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.4.1.8. Argentina OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.9. Argentina OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa OTC Scar Treatment Market Outlook, 2018 - 2031

8.1. Middle East & Africa OTC Scar Treatment Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Topical Scar Products
    - 8.1.1.1.1. Gels
    - 8.1.1.1.2. Creams/Ointments
    - 8.1.1.1.3. Oils
    - 8.1.1.1.4. Sheets
  - 8.1.1.2. Others
8.2. Middle East & Africa OTC Scar Treatment Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Atrophic Scars
  - 8.2.1.2. Hypertrophic Scars and Keloids
  - 8.2.1.3. Contractures
  - 8.2.1.4. Burns
  - 8.2.1.5. Stretch Marks
8.3. Middle East & Africa OTC Scar Treatment Market Outlook, by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals Pharmacies
  - 8.3.1.2. Retail Pharmacies
  - 8.3.1.3. E-Commerce
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa OTC Scar Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.2. GCC OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.3. GCC OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 8.4.1.4. South Africa OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.5. South Africa OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.6. South Africa OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 8.4.1.7. Egypt OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.8. Egypt OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.9. Egypt OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 8.4.1.10. Nigeria OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.11. Nigeria OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.12. Nigeria OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa OTC Scar Treatment Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa OTC Scar Treatment Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa OTC Scar Treatment Market by Distribution Channe, Value (US$ Bn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Segment 3 vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Smith & Nephew PLC
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Merz Inc
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Enaltus LLC
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Occulus Innovative Sciences Inc.
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. CCA Industries Inc
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Cynosure Inc
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Avita Medical Limited
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Lumenis
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Syneron Medical Ltd.
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Nutramarks Inc.
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Molnlycke Health Care
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Pacific World Corporation
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. Valeant Pharmaceuticals International Inc
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers)
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development
- 9.5.15. SkinCeuticals
  - 9.5.15.1. Company Overview
  - 9.5.15.2. Product Portfolio
  - 9.5.15.3. Financial Overview
  - 9.5.15.4. Business Strategies and Development
- 9.5.16. A. Menarini Singapore Pte. Ltd.
  - 9.5.16.1. Company Overview
  - 9.5.16.2. Product Portfolio
  - 9.5.16.3. Financial Overview
  - 9.5.16.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations